Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Dermatology
    • Psoriasis patients at...

    Psoriasis patients at increased risk of erectile dysfunction

    Written by Medha Baranwal Baranwal Published On 2018-10-21T19:25:50+05:30  |  Updated On 21 Oct 2018 7:25 PM IST
    Psoriasis patients at increased risk of erectile dysfunction

    Psoriasis patients are at an increased risk for erectile dysfunction (ED) and sexual dysfunction (SD), finds a systematic review published in the journal JAMA Dermatology.


    In addition, patients with psoriasis have physical and psychological comorbidities that have been associated with a higher risk of SD.


    Alejandro Molina-Leyva, Dermatología, Hospital Universitario Virgen de las Nieves, Granada, Spain, and colleagues conducted the study to evaluate the available scientific evidence regarding epidemiologic associations and treatment outcomes between psoriasis and SD and ED.


    "Psoriasis could increase the risk of sexual dysfunction, particularly in patients with psychological comorbidity; treatment should be optimized in patients with sexual dysfunction," write the authors.


    The research team reviewed 28 studies from MEDLINE and Embase databases, of which 19 were cross-sectional, three were clinical trials, three were quasi-experimental, two were population-based cohorts, and one was a population-based case-control study. The reports represented 52,520 cases of psoriasis and 1,806,022 controls.


    Also Read: Halobetasol propionate safe,effective treatment of psoriasis

    Key Findings:

    • In comparison to healthy controls, psoriasis patients had a 5.5-fold higher risk of SD and a 1.38-fold to a 3.97-fold estimated risk of having ED versus healthy controls.

    • Psoriasis was found to be an independent risk factor for SD or ED, with an estimated risk being between 1.27-fold and 2.9-fold.

    • Two of 2 studies observed an association between psoriasis and SD after adjusting for physical and psychological comorbidities.

    • Five of 8 studies observed an independent association between ED and psoriasis.

    • Among patients with psoriasis, the features that showed the strongest association with SD were anxiety and depression (5 of 5 studies), psoriatic arthritis (3 of 4 studies), and genital psoriasis (5 of 7 studies).

    • Regarding ED, anxiety, and depression (2 of 2 studies) and increasing age (3 of 3 studies) showed the strongest association.

    • All 3 clinical trials using biologic drugs showed an improvement in SD compared with placebo.

    • There was a potential higher risk of SD for females, psoriasis severity, and increasing age.

    • Anxiety, depression, and increasing age were the main features linked to a higher risk of ED in patients with psoriasis.


    Also Read: Low dose topical Steroids best for genital psoriasis

    All the reports showed a statistically significant improvement of SD for treatment of psoriasis, but the improvement was only found for women. The clinical trials data highlighted an improvement of sexual function ranging from 15% to 40% based on the varying criteria implemented to evaluate benefit in comparison with placebo.


    In studies that comparing etanercept (Enbrel) with secukinumab (Cosentyx) and ixekizumab (Taltz), there was a non-statistically significant improvement ranging from 1% to 5% for the latter drugs, the investigators reported.


    Study limitations included the fact that a substantial number of studies did not use stratified data based on the severity of SD and were cross-sectional. Also, some of the studies included healthy or dermatologic controls but were not case-control because of their methodology.


    Future studies should include "topical treatment, classic systemic drugs, and biologic drugs ... to make an evidence-based approach to the treatment of patients with psoriasis and SD," the investigators wrote.


    "Patients with psoriasis have physical and psychological comorbidities that have been associated with a higher risk of SD. In addition, psoriasis may play a role in its development. The presence of anxiety, depression, psoriatic arthritis, genital lesions, and increasing age should raise the awareness of SD. Biologic drugs have demonstrated the improvement of SD in patients with psoriasis," they concluded.



    For further reference log on to 10.1001/jamadermatol.2018.3442
    depressionDysfunctionerectileHealthJAMA Dermatologyrisksexual
    Source : With inputs from JAMA Dermatology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok